|
KIAA1598 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.05280286897414E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24200000284347E-08 |
| Normal-vs-Stage2 |
1.92509999996648E-06 |
| Normal-vs-Stage3 |
1.09709996642948E-09 |
| Normal-vs-Stage4 |
1.52829970900825E-10 |
| Stage1-vs-Stage2 |
8.503600E-01 |
| Stage1-vs-Stage3 |
1.778970E-01 |
| Stage1-vs-Stage4 |
3.812400E-02 |
| Stage2-vs-Stage3 |
4.514200E-01 |
| Stage2-vs-Stage4 |
1.149970E-01 |
| Stage3-vs-Stage4 |
3.261200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.90130022836854E-10 |
| Normal-vs-AfricanAmerican |
2.846100E-04 |
| Normal-vs-Asian |
1.08289999967148E-07 |
| Caucasian-vs-AfricanAmerican |
5.988800E-01 |
| Caucasian-vs-Asian |
9.663800E-01 |
| AfricanAmerican-vs-Asian |
5.891600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32000000321975E-08 |
| Normal-vs-Female |
1.08460018743983E-10 |
| Male-vs-Female |
9.250200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.47579999998371E-07 |
| Normal-vs-Age(41-60Yrs) |
2.89600010638935E-10 |
| Normal-vs-Age(61-80Yrs) |
4.34949998240342E-09 |
| Normal-vs-Age(81-100Yrs) |
1.116490E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.581800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.985640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.690000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.975000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.908800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.126200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.820300E-03 |
| Classical-VS-Follicular |
8.193000E-01 |
| Classical-VS-Other |
8.441800E-01 |
| Classical-VS-Normal |
5.11480002796105E-09 |
| Tall-VS-Follicular |
3.805800E-02 |
| Tall-VS-Other |
2.710000E-01 |
| Tall-VS-Normal |
2.99369995460097E-09 |
| Follicular-VS-Other |
9.162600E-01 |
| Follicular-VS-Normal |
1.2531999999954E-06 |
| Other-VS-Normal |
1.047870E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.38710212391902E-11 |
| Normal-vs-N1 |
3.92929999648572E-09 |
| N0-vs-N1 |
1.625830E-01 |
|
|
